XML 26 R15.htm IDEA: XBRL DOCUMENT
v3.24.3

NET LOSS PER SHARE | 9 Months Ended
--- | ---
Sep. 30, 2024
Earnings Per Share [Abstract] |
NET LOSS PER SHARE | NET LOSS PER SHARE The Company implemented a 1-for-5 reverse stock split of its common stock effective July 1, 2024. All calculations have been adjusted to reflect this reverse stock split for all periods presented. The table below sets forth a reconciliation of the basic and diluted earnings per share (“EPS”) calculations for the three and nine months ended September 30, 2024 and 2023:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
($ in thousands, except share and per share amounts) | 2024 |  | 2023 |  | 2024 |  | 2023
Numerator: |  |  |  |  |  |  |
Net loss | $ | (19,408) |  |  | $ | (95,361) |  |  | $ | (120,628) |  |  | $ | (133,350) |
Denominator: |  |  |  |  |  |  |
Weighted average shares outstanding - basic | 19,458,102 |  |  | 17,331,056 |  |  | 19,200,229 |  |  | 16,209,376 |
Effect of dilutive equity awards (1) | — |  |  | — |  |  | — |  |  | — |
Weighted average shares outstanding - diluted | 19,458,102 |  |  | 17,331,056 |  |  | 19,200,229 |  |  | 16,209,376 |
Net loss per share: |  |  |  |  |  |  |
Basic | $ | (1.00) |  |  | $ | (5.50) |  |  | $ | (6.28) |  |  | $ | (8.23) |
Diluted | $ | (1.00) |  |  | $ | (5.50) |  |  | $ | (6.28) |  |  | $ | (8.23) |
(1) Due to the Company’s net loss, all unvested equity awards, and the Private Placement Warrants are anti-dilutive. The dilutive convertible instruments of the Backstop Notes are out of the money. In determining the weighted average shares outstanding for the three and nine months ended September 30, 2024 for both basic and diluted earnings per share, the Company included the Penny Warrants issued to Searchlight in transactions dated November 15, 2023 and December 13, 2023, as the common shares of stock that would be issuable upon the exercise of such warrants are issuable for nominal consideration per share of common stock or cashless exercise at the option of Searchlight. The Penny Warrants were exercisable immediately upon issuance, although no such warrants had been exercised as of September 30, 2024. Set forth in the table below is the number of securities not included in the computation of diluted shares outstanding because the effect would be anti-dilutive:
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2024 |  | 2023 |  | 2024 |  | 2023
Grants of RSUs with service only (i.e., time-vesting) conditions | 811,664 |  |  | 1,489,987 |  |  | 811,664 |  |  | 1,204,350 |
Common stock issuable under the Backstop Notes (1) | 1,920,007 |  |  | 1,920,007 |  |  | 1,920,007 |  |  | 1,920,007 |
Private Placement Warrants (2) | 272,779 |  |  | 272,779 |  |  | 272,779 |  |  | 272,779 |
(1) Common stock issuable under the Backstop Notes is presented at the maximum number of shares of common stock potentially issuable upon the exercise of the Backstop Notes, although the actual potentially issuable shares remain limited at 9.9% of the common stock outstanding. (2) The number of shares of common stock covered by warrants outstanding at the effective time of the reverse stock split was reduced to one-fifth the number of shares of common stock covered by the warrants immediately preceding the reverse stock split, and the exercise price per share was increased by five times the exercise price immediately preceding the reverse stock split, resulting in the same aggregate price being required to be paid therefor upon exercise thereof as was required immediately preceding the reverse stock split. Unvested restricted stock units with “time and performance conditions” are excluded from the disclosure of the number of potentially anti-dilutive securities because the performance conditions were not met at the end of the reporting periods. Therefore, these securities are not considered to be contingently issuable for purposes of dilutive EPS or anti-dilution calculations.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration